Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: A Study of Suizenji in Patients With Unresectable Pancreatic Cancer [NA]

View source ↗

Summary

Clinical trial update for Suizenji in patients with unresectable pancreatic cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suizenji

Snippet

Sponsor: SONIRE Therapeutics Inc. | Conditions: Unresectable Pancreatic Cancer | NA | Status: ACTIVE_NOT_RECRUITING